Welcome to the Australian Bio Directory

215 Results found
All Categories
New South Wales

MINIMUM bio

Australia
MINIMUM bio specializes in accelerating drug target identification for the pharmaceutical industry, aiming to enhance drug discovery processes and reduce the time and costs associated with preclinical research and development. We specialise in the discovery of molecular glues and new drug targets.
  • Company Type (Public/Private)
Working with:
Contact person(s):
Year founded
2022
No of Employees
2-6

Biotome

Australia
Biotome is an Australian biotechnology company developing next-generation antibody diagnostics through epitope-level precision. Our proprietary platform analyzes immune responses to specific protein fragments (epitopes) rather than whole antigens, delivering superior specificity and sensitivity compared to conventional serology.Our lead product, Helitope™, is the world's first blood test to stratify gastric cancer risk by detecting antibodies against specific Helicobacter pylori virulence factor epitopes. This breakthrough diagnostic identifies H. pylori-infected individuals at highest risk for gastric adenocarcinoma, enabling targeted prevention strategies. The technology is protected by patents granted in 20 countries.Beyond our diagnostic pipeline, we provide epitope mapping services to vaccine developers, diagnostic companies, and therapeutic antibody researchers worldwide. Our platform combines proprietary peptide-ELISA technology, advanced bioinformatics pipelines, and deep immunoproteomics expertise to deliver actionable insights for antibody-based applications.
  • Company Type (Public/Private)
Working with:
Contact person(s):
Languages
  • English
Year founded
2017
No of Employees
4-6
Victoria
mexec is an Executive Search Recruitment firm that also provides support to individuals seeking to transition to a new role. We specialise in the medtech, biotech, digital health, healthcare and innovation sectors. mexec are experienced in resourcing staff for companies including executive search and selection services to build your leadership team. We offer comprehensive services for individuals including our mexec jobstrategy TM program and interview coaching. mexec works at all levels from graduate to CEO and board.
  • Company Type (Public/Private)
Working with:
Contact person(s):
Year founded
2011
No of Employees
5-10
New South Wales

Obatica Oncology & Medical

Australia
Obatica Oncology & Medical is a boutique medical focused drug development and clinical trial consultancy firm based in Sydney Australia. Services includes clinical development and commercialization strategy, clinical trial study design, medical writing, medical director, medical monitor, and pharmacovigilance services.Obatica has been involved in over than 60 clinical trial projects with sponsors from US, Canada, Singapore, EU, and Australia.Specializing in complex early phase clinical trials in Oncology, Allergy, Pain and Rare diseases. Our development experience includes small molecules, monoclonal antibodies, RNA-based therapies, cell therapies and radiotheranostics.Our Medical Writing team can produce a high quality and faster than industry standard clinical trial related documents such as synopsis, Investigational Brochure’s (IB), protocol, PICF, CSR, and regulatory related submissions for instance INTERACT, IND, DSUR.Obatica is a leading Medical and clinical trial Functional Service Provider (FSP) providing cost effective fractional allocation of practicing clinicians with clinical trials experience, providing senior medical director or sponsor medical representative roles.Our in-house specialist doctors include Medical Oncologists, General Medicine Physicians, Geriatricians, and Surgeons to support your project. Let’s have a free initial confidential chat about your drug development or clinical trial project.
  • Clinical Trial Management and Support
Working with:
Contact person(s):
Year founded
2021
No of Employees
5-10
Queensland

Resolian Bioanalytics

Australia and 1 other(s)
Resolian is a global laboratory contract research organization that provides bioanalytical and analytical sciences support for drug development, preclinical, and multi-regional clinical trials, emphasizing exceptional solutions and strong collaborative relationships. The company offers services in drug metabolism and pharmacokinetics and bioanalytical, new drugs, metabolites or generic drug assays, large molecule immunoassays, small molecule metabolite profiling and identification and biosimilar characterization, thereby assisting clients through the process of taking a drug from pre-clinical trials to market at earliest.
  • Company Type (Public/Private)
Working with:
Contact person(s):
Year founded
2007
No of Employees
20-600

Acclime Australia

Australia and 3 other(s)
Acclime Australia supports international companies, particularly foreign businesses, looking to establish and scale operations in Australia while accessing the benefits of the Australian Research & Development Tax Incentive program (R&DTI).Our team of corporate, tax, and R&D specialists assists international companies across a broad range of industries to enter the Australian market efficiently and compliantly, while taking advantage of generous benefits for innovation and technology development.Our services include:Market entry and corporate structuring advisory - Assisting companies in selecting the most appropriate structure for their Australian operations, including subsidiary incorporation, branch registration, and cross-border tax considerations.Australian company establishment and registrations – Managing the setup of Australian entities, tax registrations, and Australian bank account support to ensure a smooth market entry process.Resident Director and company officers – Providing experienced Australian/industry-based officers to satisfy local regulatory and tax residency requirements.R&D Tax Incentive advisory - Supporting companies throughout the full R&D lifecycle, including eligibility assessments, technical and financial documentation, application preparation, and ongoing compliance management.Transfer Pricing advisory – Assisting multinational groups with transfer pricing compliance and advisory services to ensure cross-border related party transactions are aligned with Australian tax regulations and transfer pricing principles.Ongoing accounting, tax, payroll, and compliance outsourcing –Enabling international companies to operate in Australia without the need to build a large internal administrative function.Registered office and operational support solutions – Allowing overseas businesses to maintain a compliant local presence while managing operations remotely.With local teams across Australia, the USA, UAE, and the Asia-Pacific region, Acclime combines international business expertise with practical on-the-ground support to help innovative companies confidently expand into Australia and successfully navigate their growth journey.
  • Company Type (Public/Private)
Working with:
Contact person(s):
Languages
  • English
Year founded
2011
No of Employees
1-2,000
Victoria

CBE Pure Solutions

Australia
CBE Pure Solutions (CBEPS) is an Australian based Contract Manufacturing Organisation (CMO), supporting Biotech and Pharmaceutical companies in the translation of Life Science products. Specialising in sterile fill and finish and microbiological testing.Established 2021, CBEPS expertise lies in providing fill and finish services and microbiological testing services. CBEPS operate a state-of-the-art facility in Melbourne’s South East Biotech precinct, designed for Good Manufacturing Practice (cGMP) compliance and international standards. The company specialises in fill and finish services for liquid medicinal products and medical devices, offering comprehensive monitoring and testing services, including environmental monitoring and sterility testing.The Clinical trial facility is Australia's only contract manufacturing facility utilising isolator technology for small scale boutique filling of specialist advanced therapy and traditional small molecule products with capability of vials and syringes from 1ml to 20ml. Licensing for Phase 2 and 3 clinical trials is anticipated in June, 2025.The facility works to cGMP across all modules and holds TGA accreditation for laboratory testing and Quality systems (Licence MI-2023-08205-1) and Animal Health APVMA (Licence 1126).
  • Company Type (Public/Private)
Working with:
Contact person(s):
Languages
  • English
Year founded
2021
No of Employees
9-12
New South Wales

Celosia Therapeutics

Australia
Celosia Therapeutics is a clinical‑stage biotechnology company developing disease‑modifying therapies for neurodegenerative disorders with high unmet need.
  • Advanced therapies including cell & gene
Working with:
Contact person(s):
Languages
  • English
Year founded
2022

Global Pharma Solutions

Australia and 1 other(s)
Global Pharma Solutions (GPS): Experienced professionals accelerating medicine registrations globally. GPS is a global regulatory and product development consulting firm with experts in both the US and Australia. We have over 22 years’ experience in developing and registering hundreds of products including small molecules, biologics and medical devices and 11 years’ experience with cell and gene therapies, particularly liaising with the FDA.We guide biotech companies through complex development pathways, ensuring a clear route to market approval.Through our partner CROs, we also offer support with clinical operations.
  • Company Type (Public/Private)
Working with:
Contact person(s):
Year founded
2003
No of Employees
5-11
NSW government delivers clinical trial facilitation, public health data research, and biobank infrastructure supporting international healthcare innovation and
  • Government
Working with:
Contact person(s):
Year founded
1856
View all Companies
Showing 1-10 of 215 results
.....